Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 102.
A
Aitken, J;
Ambrose, K;
Barrell, S;
Beale, R;
Bineva-Todd, G;
Biswas, D;
Byrne, R;
... Wu, M; + view all
(2020)
Scalable and robust SARS-CoV-2 testing in an academic center.
Nature Biotechnology
, 38
(8)
pp. 927-931.
10.1038/s41587-020-0588-y.
|
Alexiadou, K;
Cuenco, J;
Howard, J;
Wewer Albrechtsen, NJ;
Ilesanmi, I;
Kamocka, A;
Tharakan, G;
... Tan, TM-M; + view all
(2020)
Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.
BMJ Open Diabetes Research & Care
, 8
(1)
, Article e001076. 10.1136/bmjdrc-2019-001076.
|
Alwan, NA;
Burgess, RA;
Ashworth, S;
Beale, R;
Bhadelia, N;
Bogaert, D;
Dowd, J;
... Ziauddeen, H; + view all
(2020)
Scientific consensus on the COVID-19 pandemic: we need to act now.
The Lancet
, 396
(10260)
e71-e72.
10.1016/S0140-6736(20)32153-X.
|
Antonelou, Marilina;
(2020)
Investigating the role of myeloperoxidase as a key mediator of renal damage in crescentic glomerulonephritis and renocardiac disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
Antonelou, M;
Michaëlsson, E;
Evans, RDR;
Wang, CJ;
Henderson, SR;
Walker, LSK;
Unwin, RJ;
... RAVE-ITN Investigators; + view all
(2020)
Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Journal of the American Society of Nephrology
, 31
(2)
pp. 350-364.
10.1681/ASN.2019060618.
|
Ashton, E;
Bockenhauer, D;
(2020)
Diagnosis of uncertain significance: can next generation sequencing replace the clinician?
Kidney International
, 97
(3)
pp. 455-457.
10.1016/j.kint.2019.12.012.
|
B
Baggiano, A;
Boldrini, M;
Martinez-Naharro, A;
Kotecha, T;
Petrie, A;
Rezk, T;
Gritti, M;
... Fontana, M; + view all
(2020)
Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
JACC: Cardiovascular Imaging
, 13
(1(1))
pp. 69-80.
10.1016/j.jcmg.2019.03.026.
|
Bakris, G;
Oshima, M;
Mahaffey, KW;
Agarwal, R;
Cannon, CP;
Capuano, G;
Charytan, DM;
... Perkovic, V; + view all
(2020)
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m²: Subgroup Analysis of the Randomized CREDENCE Trial.
Clinical Journal of the American Society of Nephrology
10.2215/CJN.10140620.
|
Balogh, E;
Chandler, J;
Varga, M;
Tahoun, M;
Menyhárd, DK;
Schay, G;
Goncalves, T;
... Tory, K; + view all
(2020)
Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.
Proceedings of the National Academy of Sciences of the United States of America
, 117
(26)
pp. 15137-15147.
10.1073/pnas.2002328117.
|
Bertocchio, J-P;
Genetet, S;
Da Costa, L;
Walsh, SB;
Knebelmann, B;
Galimand, J;
Bessenay, L;
... Mouro-Chanteloup, I; + view all
(2020)
Red Blood Cell AE1/Band 3 Transports in Dominant Distal Renal Tubular Acidosis Patients.
Kidney International Reports
, 5
(3)
pp. 348-357.
10.1016/j.ekir.2019.12.020.
|
Bertulli, C;
Hureaux, M;
De Mutiis, C;
Pasini, A;
Bockenhauer, D;
Vargas-Poussou, R;
La Scola, C;
(2020)
A Rare Cause of Chronic Hypokalemia with Metabolic Alkalosis: Case Report and Differential Diagnosis.
Children
, 7
(11)
, Article 212. 10.3390/children7110212.
|
Brocklebank, V;
Kumar, G;
Howie, AJ;
Chandar, J;
Milford, DV;
Craze, J;
Evans, J;
... Kavanagh, D; + view all
(2020)
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy.
Kidney International
, 97
(6)
pp. 1260-1274.
10.1016/j.kint.2020.01.045.
|
C
Cannon, CP;
Perkovic, V;
Agarwal, R;
Baldassarre, J;
Bakris, G;
Charytan, DM;
De Zeeuw, D;
... Mahaffey, KW; + view all
(2020)
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial.
Circulation
, 141
(5)
pp. 407-410.
10.1161/CIRCULATIONAHA.119.044359.
|
Chacko, L;
Martone, R;
Bandera, F;
Lane, T;
Martinez-Naharro, A;
Boldrini, M;
Rezk, T;
... Fontana, M; + view all
(2020)
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
European Heart Journal
, 41
(14)
pp. 1439-1447.
10.1093/eurheartj/ehz905.
|
Chromek, M;
Jungner, Å;
Rudolfson, N;
Ley, D;
Bockenhauer, D;
Hagander, L;
(2020)
Hyponatraemia despite isotonic maintenance fluid therapy: a time series intervention study.
Archives of Disease in Childhood
10.1136/archdischild-2019-318555.
(In press).
|
Clase, CM;
Fu, EL;
Ashur, A;
Beale, RCL;
Clase, IA;
Dolovich, MB;
Jardine, MJ;
... Carrero, JJ; + view all
(2020)
Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks—A Narrative Review.
Mayo Clinic Proceedings
, 95
(10)
pp. 2204-2224.
10.1016/j.mayocp.2020.07.020.
|
Cleary, F;
Prieto-Merino, D;
Hull, S;
Caplin, B;
Nitsch, D;
(2020)
Feasibility of evaluation of the natural history of kidney disease in the general population using electronic healthcare records.
Clinical Kidney Journal
10.1093/ckj/sfaa175.
(In press).
|
Collins, L;
Sathiananthamoorthy, S;
Rohn, J;
Malone-Lee, J;
(2020)
A revalidation and critique of assumptions about urinary sample collection methods, specimen quality and contamination.
International Urogynecology Journal
10.1007/s00192-020-04272-x.
(In press).
|
Cosentino, F;
Grant, PJ;
Aboyans, V;
Bailey, CJ;
Ceriello, A;
Delgado, V;
Federici, M;
... ESC Scientific Document Group, .; + view all
(2020)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
European Heart Journal
, 41
(2)
10.1093/eurheartj/ehz486.
|
D
Downie, ML;
Lopez Garcia, SC;
Kleta, R;
Bockenhauer, D;
(2020)
Inherited Tubulopathies of the Kidney: Insights from Genetics.
Clinical Journal of the American Society of Nephrology (CJASN)
10.2215/CJN.14481119.
|
Dufek-Kamperis, Stephanie;
(2020)
Genome wide association study in steroid sensitive nephrotic syndrome.
Doctoral thesis (Ph.D), UCL (University College London).
|
E
Evans, RDR;
Antonelou, M;
Sathiananthamoorthy, S;
Rega, M;
Henderson, S;
Ceron-Gutierrez, L;
Barcenas-Morales, G;
... Salama, AD; + view all
(2020)
Inherited salt-losing tubulopathies are associated with immunodeficiency due to impaired IL-17 responses.
Nature Communications
, 11
, Article 4368. 10.1038/s41467-020-18184-3.
|
F
Fotheringham, J;
Smith, MT;
Froissart, M;
Kronenberg, F;
Stenvinkel, P;
Floege, J;
Eckardt, K-U;
(2020)
Hospitalization and mortality following non-attendance for hemodialysis according to dialysis day of the week: a European cohort study.
BMC Nephrology
, 21
, Article 218. 10.1186/s12882-020-01874-x.
|
G
Gale, D;
Mallett, A;
Patel, C;
Sneddon, TP;
Rehm, HL;
Sampson, MG;
Bockenhauer, D;
(2020)
Diagnoses of uncertain significance: kidney genetics in the 21st century.
Nature Reviews Nephrology
, 16
pp. 616-618.
10.1038/s41581-020-0277-6.
|
Gauckler, P;
Shin, JI;
Alberici, F;
Audard, V;
Bruchfeld, A;
Busch, M;
Cheung, CK;
... RITERM study group, .; + view all
(2020)
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Autoimmunity Reviews
, Article 102671. 10.1016/j.autrev.2020.102671.
(In press).
|
Giri, D;
Bockenhauer, D;
Deshpande, C;
Achermann, JC;
Taylor, NF;
Rumsby, G;
Morgan, H;
... Ajzensztejn, M; + view all
(2020)
Co-Existence of Congenital Adrenal Hyperplasia and Bartter Syndrome due to Maternal Uniparental Isodisomy of HSD3B2 and CLCNKB Mutations.
Hormone Research in Paediatrics
10.1159/000507577.
(In press).
|
Gonzalez, AM;
Gutman, T;
Lopez-Vargas, P;
Anumudu, S;
Arce, CM;
Craig, JC;
Dunn, L;
... Tong, A; + view all
(2020)
Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study.
American Journal of Kidney Diseases
, 76
(5)
pp. 679-689.
10.1053/j.ajkd.2020.03.022.
|
Govers, LP;
Toka, HR;
Hariri, A;
Walsh, SB;
Bockenhauer, D;
(2020)
Mitochondrial DNA mutations in renal disease: an overview.
Pediatric Nephrology
10.1007/s00467-019-04404-6.
(In press).
|
H
Hamilton, SA;
Nakanga, WP;
Prynn, JE;
Crampin, AC;
Fecht, D;
Vineis, P;
Caplin, B;
... Nyirenda, MJ; + view all
(2020)
Prevalence and risk factors for chronic kidney disease of unknown cause in Malawi: a cross-sectional analysis in a rural and urban population.
BMC Nephrology
, 21
, Article 387. 10.1186/s12882-020-02034-x.
|
Hanson, CS;
Craig, JC;
Logeman, C;
Sinha, A;
Dart, A;
Eddy, AA;
Guha, C;
... Tong, A; + view all
(2020)
Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology-Children and Adolescents (SONG-KIDS) consensus workshops.
Kidney International
, 98
(3)
pp. 553-565.
10.1016/j.kint.2020.05.054.
|
Heerspink, HJL;
Stefansson, BV;
Chertow, GM;
Correa-Rotter, R;
Greene, T;
Hou, F-F;
Lindberg, M;
... DAPA-CKD Investigators; + view all
(2020)
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.
Nephrology Dialysis Transplantation
, 35
(2)
pp. 274-282.
10.1093/ndt/gfz290.
|
Heerspink, HJL;
Stefánsson, BV;
Correa-Rotter, R;
Chertow, GM;
Greene, T;
Hou, F-F;
Mann, JFE;
... DAPA-CKD Trial Committees and Investigators; + view all
(2020)
Dapagliflozin in Patients with Chronic Kidney Disease.
The New England Journal of Medicine
, 383
pp. 1436-1446.
10.1056/NEJMoa2024816.
|
Houlihan, CF;
Beale, R;
(2020)
The complexities of SARS-CoV-2 serology.
The Lancet Infectious Diseases
10.1016/S1473-3099(20)30699-X.
(In press).
|
Houlihan, CF;
Vora, N;
Byrne, T;
Lewer, D;
Kelly, G;
Heaney, J;
Gandhi, S;
... SAFER Investigators; + view all
(2020)
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.
The Lancet
, 396
(10246)
e6-e7.
10.1016/S0140-6736(20)31484-7.
|
Hu, ZB;
Lu, J;
Chen, PP;
Lu, CC;
Zhang, JX;
Li, XQ;
Yuan, BY;
... Ma, KL; + view all
(2020)
Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis.
Theranostics
, 10
(6)
pp. 2803-2816.
10.7150/thno.40571.
|
I
Ilesanmi, I;
Tharakan, G;
Alexiadou, K;
Behary, P;
Alessimii, H;
Bovill-Taylor, C;
Kenkre, J;
... Tan, TM-M; + view all
(2020)
Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study.
Diabetes Care
, 44
(2)
pp. 614-617.
10.2337/dc20-1609.
|
J
Jardine, MJ;
Zhou, Z;
Mahaffey, KW;
Oshima, M;
Agarwal, R;
Bakris, G;
Bajaj, HS;
... CREDENCE Study Investigators; + view all
(2020)
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.
Journal of the American Society of Nephrology (JASN)
, 31
(5)
pp. 1128-1139.
10.1681/ASN.2019111168.
|
Jdiaa, SS;
Walsh, SB;
Bockenhauer, D;
Fakhredine, SW;
Koubar, SH;
(2020)
The hypokalemia mystery: distinguishing Gitelman and Bartter syndromes from 'pseudo-Bartter syndrome'.
Nephrology Dialysis Transplantation
10.1093/ndt/gfaa100.
(In press).
|
K
Kadkhodayi-Kholghi, N;
Bhatt, JS;
Gor, J;
McDermott, LC;
Gale, DP;
Perkins, SJ;
(2020)
The solution structure of the complement deregulator FHR5 reveals a compact dimer and provides new insights into CFHR5 nephropathy.
Journal of Biological Chemistry
, 295
(48)
pp. 16342-16358.
10.1074/jbc.ra120.015132.
|
Kalam, S;
Beale, R;
Hughes, D;
Kulasekararaj, A;
Srirangalingam, U;
(2020)
Coombs-positive Paroxysmal Nocturnal Haemoglobinuria.
Oxford Medical Case Reports
(3)
, Article omz125. 10.1093/omcr/omz125.
|
Kari, JA;
Alhasan, KA;
Albanna, AS;
Safder, OY;
Shalaby, M;
Bockenhauer, D;
El-Desoky, SM;
(2020)
Rituximab versus cyclophosphamide as first steroid sparing agent in childhood frequently relapsing and steroid dependent nephrotic syndrome.
Pediatric Nephrology
, 35
pp. 1445-1453.
10.1007/s00467-020-04570-y.
|
Kasivisvanathan, V;
Lindsay, J;
Rakshani-Moghadam, S;
Elhamshary, A;
Kapriniotis, K;
Kazantzis, G;
Syed, B;
... UCLH study group collaborators; + view all
(2020)
A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site.
International Journal of Surgery
, 84
pp. 57-65.
10.1016/j.ijsu.2020.10.019.
|
Khoo, B;
Tan, TM-M;
(2020)
Combination gut hormones: prospects and questions for the future of obesity and diabetes therapy.
Journal of Endocrinology
, 246
(3)
R65-R74.
10.1530/JOE-20-0119.
|
Khoo, B;
Tan, T;
Clarke, SA;
Mills, EG;
Patel, B;
Modi, M;
Phylactou, M;
... Dhillo, WS; + view all
(2020)
Thyroid function before, during and after COVID-19.
The Journal of Clinical Endocrinology & Metabolism
10.1210/clinem/dgaa830.
(In press).
|
Kidd, K;
Vylet'al, P;
Schaeffer, C;
Olinger, E;
Živná, M;
Hodaňová, K;
Robins, V;
... Bleyer, AJ; + view all
(2020)
Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations.
Kidney International Reports
, 5
(9)
pp. 1472-1485.
10.1016/j.ekir.2020.06.029.
|
King, JS;
Humphreys, D;
Rohn, JL;
Unnikrishnan, M;
Gutierrez, MG;
Mostowy, S;
(2020)
The great host‐pathogen war: UK cellular microbiology meeting 2020.
Cellular Microbiology
, 22
(11)
, Article e13248. 10.1111/cmi.13248.
|
L
Lamina, C;
Kronenberg, F;
Stenvinkel, P;
Froissart, M;
Forer, L;
Schönherr, S;
Wheeler, DC;
... Floege, J; + view all
(2020)
Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort.
Nephrology Dialysis Transplantation
, 35
(3)
pp. 478-487.
10.1093/ndt/gfz060.
|
Lau, W;
Rohn, J;
Dharmasena, D;
Horsley, H;
Jafari, N;
Malone-Lee, J;
Stride, E;
(2020)
Novel antibiotic-loaded particles conferring eradication of deep tissue bacterial reservoirs for the treatment of chronic urinary tract infection.
Journal of Controlled Release
, 328
pp. 490-502.
10.1016/j.jconrel.2020.08.048.
|
Law, S;
Gillmore, J;
Gilbertson, JA;
Bass, P;
Salama, AD;
(2020)
Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.
BMC Nephrology
, 21
(1)
, Article 74. 10.1186/s12882-020-01733-9.
|
Levey, AS;
Eckardt, K-U;
Dorman, NM;
Christiansen, SL;
Hoorn, EJ;
Ingelfinger, JR;
Inker, LA;
... Winkelmayer, WC; + view all
(2020)
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
Kidney International
, 97
(6)
pp. 1117-1129.
10.1016/j.kint.2020.02.010.
(In press).
|
Levin, A;
Agarwal, R;
Herrington, WG;
Heerspink, HL;
Mann, JFE;
Shahinfar, S;
Tuttle, KR;
... participant authors of the International Society of Nephrology’s; + view all
(2020)
International consensus definitions of clinical trial outcomes for kidney failure: 2020.
Kidney International
, 98
(4)
pp. 849-859.
10.1016/j.kint.2020.07.013.
|
Levin, A;
Perkovic, V;
Wheeler, DC;
Hantel, S;
George, JT;
von Eynatten, M;
Koitka-Weber, A;
... EMPA-REG OUTCOME Investigators; + view all
(2020)
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial.
Clinical Journal of the American Society of Nephrology
, 15
(10)
pp. 1433-1444.
10.2215/CJN.14901219.
|
Levine, AP;
Chan, MMY;
Sadeghi-Alavijeh, O;
Wong, EKS;
Cook, HT;
Ashford, S;
Carss, K;
... Gale, DP; + view all
(2020)
Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.
Journal of the American Society of Nephrology
, 31
(1)
10.1681/ASN.2019040433.
|
Li, Z;
Li, D;
Rao, Y;
Wei, L;
Liu, M;
Zheng, G;
Yao, Y;
... Ruan, XZ; + view all
(2020)
SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth.
Biomedicine & Pharmacotherapy
, 133
, Article 111011. 10.1016/j.biopha.2020.111011.
|
Lipska-Ziętkiewicz, BS;
Ozaltin, F;
Hölttä, T;
Bockenhauer, D;
Bérody, S;
Levtchenko, E;
Vivarelli, M;
... Boyer, O; + view all
(2020)
Genetic aspects of congenital nephrotic syndrome: a consensus statement from the ERKNet-ESPN inherited glomerulopathy working group.
European Journal of Human Genetics
10.1038/s41431-020-0642-8.
|
Logeman, C;
Guha, C;
Howell, M;
Hanson, CS;
Craig, JC;
Samuel, S;
Zappitelli, M;
... Gutman, T; + view all
(2020)
Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey.
American Journal of Kidney Diseases
, 76
(4)
pp. 533-545.
10.1053/j.ajkd.2020.03.014.
|
Lopez-Garcia, SC;
Downie, ML;
Kim, JS;
Boyer, O;
Walsh, SB;
Nijenhuis, T;
Papizh, S;
... Bockenhauer, D; + view all
(2020)
Treatment and long-term outcome in primary nephrogenic diabetes insipidus.
Nephrology Dialysis Transplantation
, Article gfaa243. 10.1093/ndt/gfaa243.
(In press).
|
Lu, CC;
Hu, ZB;
Wang, R;
Hong, ZH;
Lu, J;
Chen, PP;
Zhang, JX;
... Ma, KL; + view all
(2020)
Gut microbiota dysbiosis-induced activation of the intrarenal renin–angiotensin system is involved in kidney injuries in rat diabetic nephropathy.
Acta Pharmacologica Sinica
, 41
pp. 1111-1118.
10.1038/s41401-019-0326-5.
|
Luo, X;
Li, Y;
Yang, P;
Chen, Y;
Wei, L;
Yu, T;
Xia, J;
... Chen, Y; + view all
(2020)
Obesity induces preadipocyte CD36 expression promoting inflammation via the disruption of lysosomal calcium homeostasis and lysosome function.
EBioMedicine
, 56
, Article 102797. 10.1016/j.ebiom.2020.102797.
|
M
Macdougall, IC;
Bhandari, S;
White, C;
Anker, SD;
Farrington, K;
Kalra, PA;
Mark, PB;
... PIVOTAL investigators and committees; + view all
(2020)
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial.
Journal of the American Society of Nephrology (JASN)
, 31
(5)
pp. 1118-1127.
10.1681/ASN.2019090972.
|
Małyszko, J;
Bamias, A;
Danesh, FR;
Dębska-Ślizień, A;
Gallieni, M;
Gertz, MA;
Kielstein, JT;
... Conference Participants; + view all
(2020)
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation.
Kidney International
, 98
(6)
pp. 1407-1418.
10.1016/j.kint.2020.07.012.
|
Maughan, EF;
Michaels, J;
Miller, B;
Weir, J;
Salama, A;
Warner, E;
Ghufoor, K;
... Al Yaghchi, C; + view all
(2020)
Primary Immunoglobulin G4-Related Laryngeal Disease: A Case Series and Review of Literature.
Clinical Medicine Insights: Case Reports
, 13
pp. 1-6.
10.1177/1179547620960197.
|
Mccafferty, K;
Caplin, B;
Knight, S;
Hockings, P;
Wheeler, D;
Fan, SL;
Hulthe, J;
... Yaqoob, MM; + view all
(2020)
HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol.
BMJ Open
, 10
(9)
, Article e033923. 10.1136/bmjopen-2019-033923.
|
Moiseev, S;
Tervaert, JWC;
Arimura, Y;
Bogdanos, DP;
Csernok, E;
Damoiseaux, J;
Ferrante, M;
... Bossuyt, X; + view all
(2020)
2020 international consensus on ANCA testing beyond systemic vasculitis.
Autoimmunity Reviews
, 19
(9)
, Article 102618. 10.1016/j.autrev.2020.102618.
|
N
Ng, KW;
Faulkner, N;
Cornish, GH;
Rosa, A;
Harvey, R;
Hussain, S;
Ulferts, R;
... Kassiotis, G; + view all
(2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science
, Article eabe1107. 10.1126/science.abe1107.
(In press).
|
O
O'Lone, E;
Howell, M;
Viecelli, AK;
Craig, JC;
Tong, A;
Sautenet, B;
Herrington, WG;
... Wheeler, DC; + view all
(2020)
Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals.
Nephrology Dialysis Transplantation
, 35
(10)
pp. 1761-1769.
10.1093/ndt/gfaa008.
|
O'Lone, E;
Viecelli, AK;
Craig, JC;
Tong, A;
Sautenet, B;
Herrington, WG;
Herzog, CA;
... SONG-HD CVD Consensus Workshop Investigators; + view all
(2020)
Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop.
American Journal of Kidney Diseases
, 76
(1)
pp. 109-120.
10.1053/j.ajkd.2020.01.022.
|
Olinger, E;
Hofmann, P;
Kidd, K;
Dufour, I;
Belge, H;
Schaeffer, C;
Kipp, A;
... Devuyst, O; + view all
(2020)
Clinical and Genetic Spectra of Autosomal Dominant Tubulointerstitial Kidney Disease due to Mutations in UMOD and MUC1.
Kidney International
10.1016/j.kint.2020.04.038.
(In press).
|
Oshima, M;
Jardine, MJ;
Agarwal, R;
Bakris, G;
Cannon, CP;
Charytan, DM;
de Zeeuw, D;
... Heerspink, HJL; + view all
(2020)
Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.
Kidney International
10.1016/j.kint.2020.10.042.
(In press).
|
Oshima, M;
Neuen, BL;
Jardine, MJ;
Bakris, G;
Edwards, R;
Levin, A;
Mahaffey, KW;
... Heerspink, HJL; + view all
(2020)
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial.
The Lancet Diabetes & Endocrinology
, 8
(11)
pp. 903-914.
10.1016/S2213-8587(20)30300-4.
|
Oshima, M;
Neuen, BL;
Li, J;
Perkovic, V;
Charytan, DM;
de Zeeuw, D;
Edwards, R;
... Heerspink, HJL; + view all
(2020)
Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial.
Journal of the American Society of Nephrology
10.1681/ASN.2020050723.
(In press).
|
P
Porta, C;
Bamias, A;
Danesh, FR;
Dębska-Ślizień, A;
Gallieni, M;
Gertz, MA;
Kielstein, JT;
... Conference Participants, .; + view all
(2020)
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer.
Kidney International
, 98
(5)
pp. 1108-1119.
10.1016/j.kint.2020.06.046.
|
R
Ramesh, S;
James, MT;
Holroyd-Leduc, JM;
Wilton, SB;
Seely, EW;
Hemmelgarn, BR;
Tonelli, M;
... Ahmed, SB; + view all
(2020)
Estradiol and mortality in women with end-stage kidney disease.
Nephrology Dialysis Transplantation
, 35
(11)
pp. 1965-1972.
10.1093/ndt/gfaa126.
|
Roper, T;
Harber, M;
Jones, G;
Pitceathly, RDS;
Salama, AD;
(2020)
Delayed diagnoses of mitochondrial cytopathies in patients presenting with end stage kidney disease: two case reports.
BMC Nephrology
, 21
, Article 361. 10.1186/s12882-020-02002-5.
|
Rossignol, P;
Ruilope, LM;
Cupisti, A;
Ketteler, M;
Wheeler, DC;
Pignot, M;
Cornea, G;
... Lund, LH; + view all
(2020)
Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review.
Clinical Kidney Journal
, 13
(4)
pp. 714-719.
10.1093/ckj/sfz129.
|
Rowczenio, DM;
Youngstein, T;
Trojer, H;
Omoyinmi, E;
Baginska, A;
Brogan, P;
Papadopoulou, C;
... Lachmann, HJ; + view all
(2020)
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature.
Rheumatology
, 59
(3)
pp. 554-558.
10.1093/rheumatology/kez334.
|
S
Salama, AD;
Caplin, B;
(2020)
Lupus Nephritis and Chronic Kidney Disease.
The Journal of Rheumatology
, 47
(9)
pp. 1303-1304.
10.3899/jrheum.200566.
|
Salama, A;
(2020)
IgA Vasculitis and Anti-GBM disease: two ends of a spectrum of immune complex vasculitis.
Rheumatology
, 59
(S3)
iii118-iii122.
10.1093/rheumatology/kez540.
|
Salama, AD;
Little, MA;
(2020)
Coaxing Anti-Inflammatory Granulocytes to Prevent Ischemic Kidney Injury: A Fine Balance.
Journal of the American Society of Nephrology
, 31
(4)
pp. 668-670.
10.1681/ASN.2020020146.
|
Sharpley, FA;
Fontana, M;
Gilbertson, JA;
Gillmore, JD;
Hawkins, PN;
Mahmood, S;
Manwani, R;
... Lachmann, HJ; + view all
(2020)
Amyloidosis Diagnosed in Solid Organ Transplant Recipients.
Transplantation
, 104
(2)
pp. 415-420.
10.1097/TP.0000000000002813.
|
Shivakumar, O;
Sattar, N;
Wheeler, DC;
(2020)
Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease.
Nephrology Dialysis Transplantation
, 35
(S1)
i43-i47.
10.1093/ndt/gfz292.
|
Standing, AS;
Hong, Y;
Paisan-Ruiz, C;
Omoyinmi, E;
Medlar, A;
Stanescu, H;
Kleta, R;
... Brogan, PA; + view all
(2020)
TRAP1 chaperone protein mutations and autoinflammation.
Life Science Alliance
, 3
(2)
, Article e201900376. 10.26508/lsa.201900376.
|
Stefánsson, BV;
Heerspink, HJL;
Wheeler, DC;
Sjöström, CD;
Greasley, PJ;
Sartipy, P;
Cain, V;
(2020)
Correction of anemia by dapagliflozin in patients with type 2 diabetes.
Journal of Diabetes and its Complications
, 34
(12)
, Article 107729. 10.1016/j.jdiacomp.2020.107729.
|
Sukcharoen, K;
Sharp, SA;
Thomas, NJ;
Kimmitt, RA;
Harrison, J;
Bingham, C;
Mozere, M;
... Oram, RA; + view all
(2020)
IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank.
Kidney International Reports
, 5
(10)
pp. 1643-1650.
10.1016/j.ekir.2020.07.012.
|
Sun, H;
Sun, Z;
Varghese, Z;
Guo, Y;
Moorhead, JF;
Unwin, RJ;
Ruan, XZ;
(2020)
Nonesterified free fatty acids enhance the inflammatory response in renal tubules by inducing extracellular ATP release.
American Journal of Physiology. Renal Physiology
, 319
(2)
F292-F303.
10.1152/ajprenal.00098.2020.
|
T
Tallarita, M;
De Iorio, M;
Guglielmi, A;
Malone-Lee, J;
(2020)
Bayesian Autoregressive Frailty Models for Inference in Recurrent Events.
The International Journal of Biostatistics
, 16
(1)
, Article 20180088. 10.1515/ijb-2018-0088.
|
Tan, T;
Khoo, B;
Mills, EG;
Phylactou, M;
Patel, B;
Eng, PC;
Thurston, L;
... Dhillo, WS; + view all
(2020)
Cortisol concentrations and mortality from COVID-19 reply.
The Lancet Diabetes & Endocrinology
, 8
(10)
pp. 809-810.
10.1016/S2213-8587(20)30306-5.
|
Thaventhiran, JED;
Lango Allen, H;
Burren, OS;
Rae, W;
Greene, D;
Staples, E;
Zhang, Z;
... Smith, KGC; + view all
(2020)
Whole-genome sequencing of a sporadic primary immunodeficiency cohort.
Nature
, 583
pp. 90-95.
10.1038/s41586-020-2265-1.
|
The RECOVERY Collaborative Group;
(2020)
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report.
New England Journal of Medicine
, 383
(21)
pp. 2030-2040.
10.1056/nejmoa2022926.
|
The RECOVERY Collaborative Group;
(2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
New England Journal of Medicine
, 383
(21)
pp. 2030-2040.
10.1056/nejmoa2022926.
|
Tieu, J;
Smith, R;
Basu, N;
Brogan, P;
D'Cruz, D;
Dhaun, N;
Flossmann, O;
... Jayne, DRW; + view all
(2020)
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.
Rheumatology
, 59
(4)
e24-e32.
10.1093/rheumatology/kez640.
|
Tieu, J;
Smith, R;
Basu, N;
Brogan, P;
D'Cruz, D;
Dhaun, N;
Flossmann, O;
... Jayne, DRW; + view all
(2020)
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary.
Rheumatology
, 59
(4)
pp. 727-731.
10.1093/rheumatology/kez632.
|
Tong, A;
Levey, AS;
Eckardt, K-U;
Anumudu, S;
Arce, CM;
Baumgart, A;
Dunn, L;
... Winkelmayer, WC; + view all
(2020)
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health.
Clinical Journal of the American Society of Nephrology
, 15
(7)
pp. 937-948.
10.2215/CJN.00900120.
|
Turro, E;
Astle, WJ;
Megy, K;
Gräf, S;
Greene, D;
Shamardina, O;
Allen, HL;
... Ouwehand, WH; + view all
(2020)
Whole-genome sequencing of patients with rare diseases in a national health system.
Nature
, 583
pp. 96-102.
10.1038/s41586-020-2434-2.
|
V
Viering, DHHM;
Chan, MMY;
Hoogenboom, L;
Iancu, D;
de Baaij, JHF;
Tullus, K;
Kleta, R;
(2020)
Genetics of renovascular hypertension in children.
Journal of Hypertension
, 38
(10)
pp. 1964-1970.
10.1097/HJH.0000000000002491.
|
W
Wan, ER;
Woolfson, RG;
Greenwood, R;
Walsh, SB;
(2020)
Transient Renal Tubular Syndromes Associated With Acute COVID-19 Disease.
Kidney International Reports
, 5
(9)
pp. 1610-1611.
10.1016/j.ekir.2020.06.037.
|
Wei, Wei;
Pagnamenta, Alistair T;
Gleadall, Nicholas;
Sanchis-Juan, Alba;
Stephens, Jonathan;
Broxholme, John;
Tuna, Salih;
... Chinnery, Patrick F; + view all
(2020)
Author Correction: Nuclear-mitochondrial DNA segments resemble paternally inherited mitochondrial DNA in humans.
Nature Communications
, 11
, Article 3741. 10.1038/s41467-020-17572-z.
|
Weiner, M;
Goh, SM;
Mohammad, AJ;
Hrušková, Z;
Tanna, A;
Sharp, P;
Kang, A;
... Segelmark, M; + view all
(2020)
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
The Journal of Rheumatology
, 47
(2)
10.3899/jrheum.190019.
|
Wheeler, DC;
James, J;
Patel, D;
Viljoen, A;
Ali, A;
Evans, M;
Fernando, K;
... as part of the Improving Diabetes Steering Committee, .; + view all
(2020)
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes.
Diabetes Therapy
10.1007/s13300-020-00930-x.
(In press).
|
Wheeler, DC;
Stefansson, BV;
Batiushin, M;
Bilchenko, O;
Cherney, DZI;
Chertow, GM;
Douthat, W;
... Heerspink, HJL; + view all
(2020)
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
Nephrology Dialysis Transplantation
10.1093/ndt/gfaa234.
(In press).
|
X
Xie, J;
Liu, L;
Mladkova, N;
Li, Y;
Ren, H;
Wang, W;
Cui, Z;
... Kiryluk, K; + view all
(2020)
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.
Nature Communications
, 11
(1)
, Article 1600. 10.1038/s41467-020-15383-w.
|
Y
Yang, P;
Zeng, H;
Tan, W;
Luo, X;
Zheng, E;
Zhao, L;
Wei, L;
... Chen, Y; + view all
(2020)
Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR.
FASEB Journal
, 34
(4)
pp. 5658-5672.
10.1096/fj.201902777RR.
|